OAKLAND, CALIFORNIA, UNITED STATES, July 3, 2024 /EINPresswire.com/ — xCures, a healthcare data platform provider, announced that the US Food and Drug Administration (FDA) has approved an Expanded Access Program (E...

May 17, 2024 -- Imaging Biometrics (IB), Elm Grove, WI, a wholly owned subsidiary of IQ-AI Ltd (LSE: IQAI), announces the successful deployment of its state-of-the-art software at Insel Gruppe AG in Bern, Switzerland. Th...

May 10, 2024 – Imaging Biometrics, LLC (IB), a wholly owned subsidiary of IQ-AI Ltd (LSE: IQAI), is highlighting a study published in Neuroradiology that validates the benefit of IB Rad Tech for distinguishing treatment ...

March 12, 2024 -- Imaging Biometrics, LLC (IB), Elm Grove, WI, a wholly owned subsidiary of IQ-AI Ltd (LSE: IQAI, OTCBB: IQAIF), is pleased to announce the results of a study published in the American Journal of Neurorad...

October 18, 2023 -- Imaging Biometrics, LLC (IB), Milwaukee, WI, a wholly owned subsidiary of IQ-AI Ltd (LSE: IQAI), is pleased to announce the results of a landmark study published in the journal, Nature Communications....

September 21, 2023 - Imaging Biometrics, LLC is pleased to announce the results of a study that validates IB Neuro’s processing of reduced-dose gadolinium-based contrast agent (GBCA) perfusion studies on 1.5T scanners....

June 27, 2023 -- Imaging Biometrics, LLC (IB), a wholly-owned subsidiary of IQ-AI Ltd (LSE: IQAI, OTCQB: IQAIF), is pleased to share the results of two pre-clinical studies that were presented at last week’s 2023 Society...

April 20, 2023 – Prism Clinical Imaging, Inc. (Prism), experts in brain mapping software and applications, and Imaging Biometrics, LLC (IB), a provider of quantitative imaging solutions, today announced a partnership to ...